Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Gilead-Sciences
Company Monitoring Page for Gilead-Sciences
latest headlines for company on cafepharma
Combo study of Gilead antiviral, Lilly anti-inflammatory drug positive in Covid-19, but raises pricing jitters
MedCity News
Wed, 09/16/20 - 07:47 pm
Tags:
Eli Lilly
,
olumiant
,
Gilead Sciences
,
remdesivir
,
Veklury
,
drug pricing
,
COVID-19
Gilead gets FDA breakthrough therapy status for magrolimab in MDS
Pharmaceutical Business Review
Wed, 09/16/20 - 10:37 am
Tags:
Gilead Sciences
,
FDA
,
MDS
,
magrolimab
,
breakthrough therapy
Shares of Lilly and Incyte gain after late-stage study finds their arthritis drug can help reduce COVID-19 recovery time
Marketwatch
Mon, 09/14/20 - 10:21 am
Tags:
Eli Lilly
,
Incyte
,
olumiant
,
COVID-19
,
remdesivir
,
Gilead Sciences
Gilead to buy cancer drugmaker Immunomedics for $21B
BioPharma Dive
Sun, 09/13/20 - 10:26 pm
Tags:
Gilead Sciences
,
M&A
,
cancer
,
Immunomedics
Gilead’s Kite submits FDA approval application for CAR-T in slow-growing lymphomas
MedCity News
Tue, 09/8/20 - 10:40 am
Tags:
Gilead Sciences
,
Yescarta
,
follicular lymphoma
,
marginal zone lymphoma
,
ASCO 2020
,
Kite Pharma
After Bristol snub, Gilead pens $120M upfront, $685M in biobucks for early Jounce cancer program
Fierce Biotech
Tue, 09/1/20 - 10:59 am
Tags:
Jounce Therapeutics
,
Gilead Sciences
,
Bristol-Myers Squibb
,
biobucks
,
immuno-oncology
FDA extends remdesivir's emergency use authorization to all hospitalized COVID-19 patients
Beckers Hospital Review
Mon, 08/31/20 - 10:16 am
Tags:
FDA
,
Gilead Sciences
,
remdesivir
,
COVID-19
,
Emergency Use Authorization
Kronos Bio raises $155M in private financing to advance lead leukemia drug into registration study next year
MedCity News
Tue, 08/25/20 - 10:28 am
Tags:
Kronos Bio
,
leukemia
,
Gilead Sciences
,
entospletinib
2 major FDA rejections leave some pharma investors worried about intensification of regulations
Beckers Hospital Review
Thu, 08/20/20 - 10:51 pm
Tags:
FDA
,
drug approvals
,
drug development
,
Gilead Sciences
,
Biomarin
How Feds Decide On Remdesivir Shipments To States Remains Mysterious
NPR
Wed, 08/19/20 - 11:40 pm
Tags:
Gilead Sciences
,
remdesivir
,
COVID-19
FDA rejects Gilead's would-be blockbuster filgotinib over toxicity concerns
Fierce Biotech
Wed, 08/19/20 - 09:23 am
Tags:
Gilead Sciences
,
filgotinib
,
rheumatoid arthritis
,
FDA
,
clinical trials
Gilead expands Tango alliance, continuing a busy year of cancer deals
Biopharma Dive
Tue, 08/18/20 - 10:53 pm
Tags:
Gilead Sciences
,
Tango Therapeutics
,
oncology
US to test benefits of remdesivir with second drug
Beckers Hospital Review
Tue, 08/18/20 - 11:02 am
Tags:
Gilead Sciences
,
remdesivir
,
beta interferon
,
clinical trials
,
COVID-19
Gilead got a boost from a newly approved PrEP drug. Now, a major insurer is dropping coverage
MedCity News
Fri, 08/14/20 - 12:01 am
Tags:
Gilead Sciences
,
UnitedHealthcare
,
PrEP
,
HIV
,
Descovy
,
Truvada
Researchers call out Gilead over diversity of remdesivir trials
Fierce Biotech
Wed, 08/12/20 - 12:20 pm
Tags:
clinical trials
,
coronavirus
,
COVID-19
,
Gilead Sciences
,
remdesivir
,
racial disparity
Gilead Sciences Submits New Drug Application for Remdesivir as a COVID-19 Treatment
Motley Fool
Mon, 08/10/20 - 11:09 pm
Tags:
Gilead Sciences
,
FDA
,
Emergency Use Authorization
,
NDAs
,
antivirals
,
COVID-19
,
Veklury
Kite, a Gilead Company, Looks to Expand Its Cell Therapy Maryland Operations
BioSpace
Mon, 08/10/20 - 10:55 pm
Tags:
Kite Pharma
,
Gilead Sciences
,
Maryland
,
cell therapy
Pfizer, Moderna and Gilead reputations climb on COVID-19 vaccine and treatment news, according to Harris Poll
Fierce Pharma
Mon, 08/10/20 - 12:14 pm
Tags:
Pfizer
,
Gilead Sciences
,
Moderna Therapeutics
,
vaccines
,
reputation
Pfizer signs deal with Gilead to manufacture COVID-19 antiviral remdesivir
Pharmaforum
Fri, 08/7/20 - 11:11 am
Tags:
Pfizer
,
Gilead Sciences
,
remdesivir
,
COVID-19
,
pandemic
,
drug manufacturing
Gilead's COVID med remdesivir is scarce and costly, AGs say, urging feds to sidestep its patents
Fierce Pharma
Wed, 08/5/20 - 11:14 pm
Tags:
Gilead Sciences
,
remdesivir
,
COVID-19
,
FDA
,
NIH
,
HHS
,
drug pricing
Pages
« first
‹ previous
…
15
16
17
18
19
20
21
22
23
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.